478 related articles for article (PubMed ID: 25983292)
21. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
22. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.
Portales-Cervantes L; Niño-Moreno P; Doníz-Padilla L; Baranda-Candido L; García-Hernández M; Salgado-Bustamante M; González-Amaro R; Portales-Pérez D
Hum Immunol; 2010 Aug; 71(8):818-25. PubMed ID: 20493226
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic alteration of the programmed cell death 1 in rheumatoid arthritis.
Tseng CC; Lin YZ; Lin CH; Li RN; Tsai WC; Ou TT; Wu CC; Sung WY; Yen JH
Eur J Clin Invest; 2019 Oct; 49(10):e13094. PubMed ID: 30810221
[TBL] [Abstract][Full Text] [Related]
25. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
26. Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells.
Lai NS; Koo M; Yu CL; Lu MC
Clin Exp Immunol; 2017 Mar; 187(3):327-336. PubMed ID: 27880973
[TBL] [Abstract][Full Text] [Related]
27. Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.
Lin YZ; Li RN; Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Autoimmunity; 2014 Feb; 47(1):23-6. PubMed ID: 24219225
[TBL] [Abstract][Full Text] [Related]
28. Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.
Atehortúa L; Rojas M; Vásquez G; Muñoz-Vahos CH; Vanegas-García A; Posada-Duque RA; Castaño D
Arthritis Res Ther; 2019 Jan; 21(1):34. PubMed ID: 30674349
[TBL] [Abstract][Full Text] [Related]
29. Association between PDCD1, CTLA4, and MECP2 gene polymorphisms and systemic lupus erythematosus in the Chinese Northern Han.
Dong HR; Li HS; Wang SC; Balin QM; Chang PY
Genet Mol Res; 2015 Dec; 14(4):17567-73. PubMed ID: 26782401
[TBL] [Abstract][Full Text] [Related]
30. IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.
Farah Izati A; Wong KK; Che Maraina CH
Malays J Pathol; 2020 Dec; 42(3):333-347. PubMed ID: 33361714
[TBL] [Abstract][Full Text] [Related]
31. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
32. The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.
Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Baumgrass R; Stuhlmüller B; Maslinski W; Hiepe F; Burmester GR; Radbruch A; Häupl T; Grützkau A
J Mol Med (Berl); 2012 Nov; 90(11):1295-309. PubMed ID: 22610275
[TBL] [Abstract][Full Text] [Related]
33. Early environmental exposure and the development of lupus.
Edwards CJ; Cooper C
Lupus; 2006; 15(11):814-9. PubMed ID: 17153856
[TBL] [Abstract][Full Text] [Related]
34. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
[TBL] [Abstract][Full Text] [Related]
35. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
Gianchecchi E; Delfino DV; Fierabracci A
Autoimmun Rev; 2013 Sep; 12(11):1091-100. PubMed ID: 23792703
[TBL] [Abstract][Full Text] [Related]
36. [Detecting shared pathways linked to rheumatoid arthritis with other autoimmune diseases in a in silico analysis].
Zheng WY; Zheng WX; Hua L
Mol Biol (Mosk); 2016; 50(3):530-9. PubMed ID: 27414792
[TBL] [Abstract][Full Text] [Related]
37. Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Addobbati C; de Azevêdo Silva J; Tavares NA; Monticielo O; Xavier RM; Brenol JC; Crovella S; Chies JA; Sandrin-Garcia P
Ann Hum Genet; 2016 Jan; 80(1):1-6. PubMed ID: 26464189
[TBL] [Abstract][Full Text] [Related]
38. Periodontitis and systemic lupus erythematosus.
Sete MR; Figueredo CM; Sztajnbok F
Rev Bras Reumatol Engl Ed; 2016; 56(2):165-70. PubMed ID: 27267530
[TBL] [Abstract][Full Text] [Related]
39. Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.
Eggleton P; Harries LW; Alberigo G; Wordsworth P; Viner N; Haigh R; Donnelly S; Jones HW; Chikanza IC; O'Conner TW; Thomson AE; Winyard PG
J Clin Immunol; 2010 Sep; 30(5):649-58. PubMed ID: 20532967
[TBL] [Abstract][Full Text] [Related]
40. [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome].
Bernard F; Romano A; Granel B
Rev Med Interne; 2010 Feb; 31(2):116-27. PubMed ID: 19962219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
